{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://thehrtindex.com/#organization",
      "name": "The HRT Index LLC",
      "url": "https://thehrtindex.com/"
    },
    {
      "@type": "WebSite",
      "@id": "https://thehrtindex.com/#website",
      "url": "https://thehrtindex.com/",
      "name": "The HRT Index",
      "publisher": {
        "@id": "https://thehrtindex.com/#organization"
      },
      "inLanguage": "en-US"
    },
    {
      "@type": "Article",
      "@id": "https://thehrtindex.com/research/menopause-statistics/#article",
      "url": "https://thehrtindex.com/research/menopause-statistics/",
      "mainEntityOfPage": {
        "@type": "WebPage",
        "@id": "https://thehrtindex.com/research/menopause-statistics/"
      },
      "isPartOf": {
        "@id": "https://thehrtindex.com/#website"
      },
      "headline": "Menopause Statistics 2026: What the Evidence Shows and Where Each Number Comes From",
      "description": "Menopause statistics for 2026: 19 symptom rates from 482,067 women, age and duration data, and the verified source behind every number.",
      "author": {
        "@type": "Organization",
        "name": "The HRT Index Editorial Team"
      },
      "publisher": {
        "@id": "https://thehrtindex.com/#organization"
      },
      "datePublished": "2026-08-01",
      "dateModified": "2026-08-01",
      "inLanguage": "en-US",
      "isAccessibleForFree": true,
      "about": [
        {
          "@type": "Thing",
          "name": "Menopause"
        },
        {
          "@type": "Thing",
          "name": "Perimenopause"
        },
        {
          "@type": "Thing",
          "name": "Postmenopause"
        },
        {
          "@type": "Thing",
          "name": "Vasomotor symptoms"
        },
        {
          "@type": "Thing",
          "name": "Primary ovarian insufficiency"
        }
      ],
      "keywords": [
        "menopause statistics",
        "menopause data",
        "menopause symptom statistics",
        "hot flash statistics",
        "average age of menopause",
        "menopause workplace statistics",
        "menopause treatment statistics"
      ]
    },
    {
      "@type": "Dataset",
      "@id": "https://thehrtindex.com/research/menopause-statistics/#dataset",
      "url": "https://thehrtindex.com/research/menopause-statistics/#data-files-and-data-dictionary",
      "name": "The HRT Index Menopause Statistics Evidence Ledger",
      "description": "A normalized evidence ledger of menopause statistics with populations, denominators, confidence intervals, study designs, limitations, source URLs, safe quotation language, and verification dates.",
      "creator": {
        "@type": "Organization",
        "name": "The HRT Index Editorial Team"
      },
      "publisher": {
        "@id": "https://thehrtindex.com/#organization"
      },
      "datePublished": "2026-08-01",
      "dateModified": "2026-08-01",
      "version": "1.0",
      "inLanguage": "en-US",
      "isAccessibleForFree": true,
      "measurementTechnique": "Manual claim-level extraction and denominator normalization from official health-agency sources, peer-reviewed research, an international evidence-based guideline, and transparent arithmetic.",
      "keywords": [
        "menopause statistics",
        "menopause symptom prevalence",
        "hot flashes",
        "vasomotor symptoms",
        "menopause duration",
        "menopause age",
        "menopause treatment",
        "menopause workplace data",
        "primary ovarian insufficiency"
      ],
      "variableMeasured": [
        {
          "@type": "PropertyValue",
          "name": "Symptom prevalence"
        },
        {
          "@type": "PropertyValue",
          "name": "Age at natural menopause"
        },
        {
          "@type": "PropertyValue",
          "name": "Vasomotor symptom duration"
        },
        {
          "@type": "PropertyValue",
          "name": "Annual menopause count claims"
        },
        {
          "@type": "PropertyValue",
          "name": "Work outcomes"
        },
        {
          "@type": "PropertyValue",
          "name": "Treatment prevalence"
        },
        {
          "@type": "PropertyValue",
          "name": "Primary ovarian insufficiency prevalence"
        }
      ],
      "distribution": [
        {
          "@type": "DataDownload",
          "name": "Menopause Statistics Evidence Ledger — CSV",
          "encodingFormat": "text/csv",
          "contentUrl": "https://thehrtindex.com/research/menopause-statistics/menopause-statistics.csv"
        },
        {
          "@type": "DataDownload",
          "name": "Menopause Statistics Evidence Ledger — JSON",
          "encodingFormat": "application/json",
          "contentUrl": "https://thehrtindex.com/research/menopause-statistics/menopause-statistics.json"
        }
      ]
    },
    {
      "@type": "FAQPage",
      "@id": "https://thehrtindex.com/research/menopause-statistics/#frequently-asked-questions",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What is the average age of menopause?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Most women experience natural menopause between ages 45 and 55, according to WHO. NIH gives an average U.S. age of 51, CDC says menopause usually occurs around age 52, and SWAN reported a cohort median natural final-menstrual-period age of 52.54."
          }
        },
        {
          "@type": "Question",
          "name": "What percentage of women experience menopause symptoms?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "There is no single percentage. A 2024 meta-analysis of 321 studies covering 482,067 middle-aged women reported pooled estimates for 19 symptoms ranging from 20.50% to 65.43%. Seven of the 19 point estimates were above 50%, and the authors rated the evidence certainty very low."
          }
        },
        {
          "@type": "Question",
          "name": "What was the highest pooled menopause symptom estimate?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Joint and muscular discomfort had the highest point estimate among the 19 symptoms in the 2024 meta-analysis, at 65.43% with a 95% confidence interval of 62.51% to 68.29%. That result belongs to one highly heterogeneous synthesis and should not be restated as a universal rate."
          }
        },
        {
          "@type": "Question",
          "name": "What percentage of women have hot flashes?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The 2024 meta-analysis estimated pooled hot-flash prevalence at 52.65% among middle-aged women. Its stage-specific estimates were 31.31% in premenopause, 56.52% in perimenopause, and 56.74% in postmenopause. Figures near 80% generally refer to the broader category of vasomotor symptoms and are often stated as an upper bound."
          }
        },
        {
          "@type": "Question",
          "name": "How long do hot flashes last?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Among 1,449 SWAN participants who reported frequent vasomotor symptoms, the median total duration was 7.4 years. Among 881 participants with an observable final menstrual period, the median persistence afterward was 4.5 years. These are subgroup medians, not averages for all women."
          }
        },
        {
          "@type": "Question",
          "name": "How many U.S. women reach menopause each year?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "NIH states that more than 1 million U.S. women experience menopause each year. Two more precise figures—6,000 per day and 1.3 million per year—are widely repeated but differ by 890,000 women annually and were not resolved in this audit to one original current national incidence calculation."
          }
        },
        {
          "@type": "Question",
          "name": "How many women worldwide are postmenopausal?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The audited sources do not provide a current observed global count based on directly measured menopause status. WHO reports that women aged 50 and older represented 26% of women and girls globally in 2021. A 1996 model using age 50 as a proxy projected 1.2 billion menopausal and postmenopausal women by 2030."
          }
        },
        {
          "@type": "Question",
          "name": "How common is primary ovarian insufficiency?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The current international guideline reports that non-iatrogenic primary ovarian insufficiency affects approximately 1% to 3.5% of women, depending on the study era and population. POI is defined as loss of ovarian activity before age 40."
          }
        },
        {
          "@type": "Question",
          "name": "What percentage of U.S. women receive menopause treatment?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "An AARP/NORC analysis of pooled 2016–2021 MEPS data estimated that 5% of all U.S. women ages 45–64 were treated for menopause, equivalent to 2.1 million women in its average annual estimate. The report estimated that this represented about 20%–25% of women in menopause."
          }
        },
        {
          "@type": "Question",
          "name": "How does menopause affect work?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "In a survey of 4,440 employed respondents at four Mayo Clinic sites, 13.4% reported at least one adverse work outcome attributed to menopause symptoms and 10.8% reported missed work. The study extrapolated $1.8 billion in annual U.S. lost work time; that figure is not a total economic cost."
          }
        }
      ]
    }
  ]
}